TrialScientific reports2021

Normobaric oxygen treatment for mild-to-moderate depression: a randomized, double-blind, proof-of-concept trial.

Yehudit Bloch et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.